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RESULTS
Studies discussed in the following portion of the paper are illustrated in FIGURES 1 through 6 which demonstrate the effects of sulfated and nonsulfated polyanions on platelet aggregation under conditions specified.
DISCUSSION
Some insight into the molecular properties required for activation of platelets is derived by our comparative studies of the various polyanions. Dextran sulfate of molecular weight 500,000 was more effective than dextran sulfate of molecular weight 40,000 (FIG. 5C) . The degree of sulfation is stated by the manufacturer to be the same. Therefore, chain length is an important factor. Dextran, sulfated and nonsulfated, of the same molecular weight, 500,000, also were compared. No platelet aggregation was possible with any concentration of dextran when the conditions of observation were 37" C with stirring. If, however, the conditions were room temperature and no stirring, platelets clumped in a high concentration of both forms of dextran ( 5 % ) . The clumps were easily dispersed by shaking. This is similar to the results reported by Taketomi and Ku~amoto.~ The same percent dextran ( 5 % ) completely inhibited platelet aggregation by ADP, epinephrine and collagen, as did similar concentrations of the sulfated polyanions. This inhibition may be a result of coating of the platelet with polymers leading to nonspecific interference with activation of the platelet.
High concentration of polymethacrylic acid (25 pg/ml) was found to induce a slight platelet aggregation response, but another polyanion, poly-~-glutamic acid was without any activity. Thus, a negative charge on the polymer is a necessary, but not a sufficient condition, for activation.
All of the sulfated polyanions studied could induce some platelet aggrega- heparin also was found to accelerate the rate of formation of a complex of antithrombin 111 with plasmin.7 This would increase the rate of inhibition of proteolytic and esterolytic activity of this protease. It is possible that low concentrations of heparin increase the formation of plasmin, while excess heparin would interfere with the activity of this enzyme once it is formed. If plasmin is responsible for platelet aggregation produced when polyanions are present, an optimal concentration of polyanion would, therefore, be expected to be most effective in inducing aggregation.
Inhibition of aggregation by the sulfated polyanions occurred at low concentrations of the plasmin inhibitor antithrombin 111 (2.94 u/ml) (FIG. 5A) 
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well as with C1 esterase inhibitor (not shown) and also occurred with low concentration of epsilon aminocaproic acid (0.0065 M) (FIG. 5B) , an inhibitor of plasminogen activation.8* These findings also may be taken as evidence to support the concept that activated plasrninogen is capable of inducing platelet aggregation and that the sulfated polyanions exert their action by means of this protease. In summary, we find sulfated polyanions induce platelet aggregation indirectly by activation of a plasma factor. On a weight basis, the amount of polyanion needed to induce threshold aggregation, is a function of the degree
